Treatments for intracranial hypertension in acute brain-injured patients: grading, timing, and association with outcome. Data from the SYNAPSE-ICU study
Quartile
Glasgow Outcome Scale
Grading scale
DOI:
10.1007/s00134-022-06937-1
Publication Date:
2023-01-09T13:11:05Z
AUTHORS (216)
ABSTRACT
Uncertainties remain about the safety and efficacy of therapies for managing intracranial hypertension in acute brain injured (ABI) patients. This study aims to describe therapeutical approaches used ABI, with/without pressure (ICP) monitoring, among different pathologies across countries, their association with six months mortality neurological outcome.A preplanned subanalysis SYNAPSE-ICU study, a multicentre, prospective, international, observational cohort describing ICP treatment, graded according Therapy Intensity Level (TIL) scale, patients ABI during first week intensive care unit (ICU) admission.2320 were included analysis. The median age was 55 (I-III quartiles = 39-69) years, 800 (34.5%) female. During from ICU admission, no-basic TIL 382 (16.5%) patients, mild-moderate 1643 (70.8%), extreme 295 cases (eTIL, 12.7%). Patients who received eTIL younger (median 49 35-62) vs 56 (40-69) p < 0.001), less cardiovascular pre-injury comorbidities (859 (44%) 90 (31.4%), more episodes neuroworsening (160 (56.1%) 653 (33.3%), frequently monitored an device (221 (74.9%) 1037 (51.2%), 0.001). Considerable variability frequency use type adopted observed between centres countries. At months, had increased risk (Hazard ratio, HR 1.612, 95% Confidence Interval, CI 1.243-2.091, 0.001) compared eTIL. No difference when comparing (HR 1.017, 0.823-1.257, 0.873). significant outcome observed.During control high are used, especially TIL. In selected aggressive strategies can have beneficial effect on but not outcome.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (31)
CITATIONS (19)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....